Faulty reasoning signals

• Confirmation Bias - 13.4% (18 hits)
• Anchoring Bias - 0%
• Availability Heuristic - 0%
• Representativeness Heuristic - 19.4% (26 hits)
• Hindsight Bias - 0%
• Overconfidence Bias - 0%
• Framing Effect - 50% (67 hits)
• Loss Aversion - 0%
• Status Quo Bias - 0%
• Sunk Cost Effect - 0%
• Optimism Bias - 0%
• Pessimism Bias - 0%

Article text

GOP lawmakers push Trump’s FDA to make sure clinical trials are diverse

WASHINGTON — Clinical trial policy got caught up in the Trump administration’s attack on policies related to diversity, equity, and inclusion.

Republicans in Congress would like to change that.

Days after Trump took office, the Health and Human Services Department began purging all references to DEI from the websites of its agencies.

Those efforts were supposed to target DEI initiatives focused on hiring practices, communications, and social issues.

But supporters of clinical trial diversity say the policy has nothing to do with DEI in that sense.

Instead, it aims to ensure that clinical trials enroll people who are similar to the patients who would use the drugs and medical devices being tested.

To read the rest of this story subscribe to STAT+.